Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview. - Wikidata - awgldk - TriplyDB

Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview.

Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview.

http://www.wikidata.org/entity/Q37824829

about

SIBLINGs and SPARC families: their emerging roles in pancreatic cancer Imaging in pancreatic disease.Molecular Imaging of Pancreatic Cancer with Antibodies.A novel multiplex-protein array for serum diagnostics of colon cancer: a case-control study Serum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinoma Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma.Genetic and molecular alterations in pancreatic cancer: implications for personalized medicine.Quantitative analysis of single amino acid variant peptides associated with pancreatic cancer in serum by an isobaric labeling quantitative method.A meta analysis of pancreatic microarray datasets yields new targets as cancer genes and biomarkers.MUC1 selectively targets human pancreatic cancer in orthotopic nude mouse models.CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer Role of IL-6 in the resolution of pancreatitis in obese mice Application of a Serum Protein Signature for Pancreatic Cancer to Separate Cases from Controls in a Pancreatic Surveillance Cohort.Advances in biomarker research for pancreatic cancer.A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma.Abnormal expression levels of sMICA and NKG2D are correlated with poor prognosis in pancreatic cancer.Differential gene expression analysis of peripheral blood mononuclear cells reveals novel test for early detection of pancreatic cancer.Strategies for discovering novel pancreatic cancer biomarkers.Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma Identification of key regulators of pancreatic cancer progression through multidimensional systems-level analysis Pancreatic cancer screening Identification of KIAA1199 as a Biomarker for Pancreatic Intraepithelial Neoplasia Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis.Preoperative evaluation and management of the pancreatic head mass.Mucins in pancreatic cancer and its microenvironment.Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9.Clinical approach to the patient with a solid pancreatic mass.Diagnostic value of S100P for pancreatic cancer: a meta-analysis.Prognostic factors related with survival in patients with pancreatic adenocarcinoma Biomarkers for pancreatic cancer: recent achievements in proteomics and genomics through classical and multivariate statistical methods.Pancreatic cancer: diagnosis and treatments.Diversity of assessing circulating tumor cells (CTCs) emphasizes need for standardization: a CTC Guide to design and report trials.The need for effective pancreatic cancer detection and management: a biomarker-based strategy.Current and future biomarkers for pancreatic adenocarcinoma.Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis.Mining the malignant ascites proteome for pancreatic cancer biomarkers.Implication of suspicious cytology in endoscopic ultrasound-guided fine-needle aspiration for pancreatic cancer.A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study.Plasma protein profiling in a stage defined pancreatic cancer cohort - Implications for early diagnosis.Combined detection of serum UL16-binding protein 2 and macrophage inhibitory cytokine-1 improves early diagnosis and prognostic prediction of pancreatic cancer.

P2860

Q27027759-4AE17DB4-852A-4B45-A655-85121713DECC Q30275458-B43E8CE5-1356-4C09-A3E8-4F187866EB11 Q30393523-066E3096-FC3C-422E-8738-09095B163C35 Q34407192-18FD08B3-C14E-4FCD-9368-CEB46316AA13 Q34483897-2118AD3B-B766-4CD0-BE1A-FE9BC08FED65 Q34644418-4A4EDFE4-B2C0-42E3-985A-CBD392BB60C4 Q34657038-3D4F976C-B341-471E-AA65-D270C4361BE8 Q34669441-C75EAFBA-9594-427D-9732-794862A0FFA7 Q35150412-862CDE03-830C-4AB8-AAE2-C38D9538AF39 Q35225232-AF4BE744-BC90-4026-AAC8-69F255A4B285 Q35485418-389E9882-CA8E-4C41-BE5E-9F7E12726C01 Q35988584-FA4E2AB7-D305-40D2-A4BC-9DB8FC4BDFA6 Q36042474-6BF536AC-6985-4BFC-8438-B8660CF5C346 Q36126609-A4E44CD3-BD95-44C6-8D74-79654A4A1F1A Q36261071-73B9068C-E4A7-4F8F-8A08-5FBD2DC14B48 Q36412775-39278B80-DFFD-4FA3-8DC5-C6B13A6CB172 Q36570435-EF0518C3-FAA8-4069-B157-0B9E2BA3B98C Q36579311-6814297C-BA6E-43AD-A33D-A3062890108F Q36793155-C953EBA1-DE2C-41D1-948C-D715EC829F6F Q36860719-B274EFEB-5D32-4D97-8187-DA0EE4D4D85E Q36896536-FD086C56-FE65-4D54-B468-5A86112F3FD6 Q37476029-AABE509D-0865-4610-A0BD-8F2E48392254 Q37714287-DB68F23D-D26B-4A40-B98E-4F9710B30984 Q38016795-95884375-C922-466A-A7C9-733434B542FC Q38121746-8EEEF002-B96B-4D64-B0BA-63EEC2D9433A Q38129331-C2E3C03D-768D-411B-AF37-4365683F04B5 Q38191823-4032D6DD-E80C-47C1-BE4D-6DF342441517 Q38239858-A500662A-388D-4C3C-BA04-91B349EF5509 Q38242807-7F2A45CD-3136-4D3F-A9E4-45ED8B8EA8D2 Q38259536-3491D1FB-5233-46A2-A8A3-594F9DB68157 Q38354856-92CAB697-3B79-43A0-A897-CD5AB855F7AB Q38577436-0F06E4A3-E5A8-470D-91BE-46C491780681 Q38591066-5DFE64FA-E58E-4206-B79E-E99E111F02C6 Q38670577-B918E421-91E2-4AA1-A64B-F94397CA7F50 Q38946461-CBE8F44B-96C5-4EBB-9722-3BB26965C980 Q39705901-689E512A-BECB-4755-A526-4324525B48A8 Q41598122-40857330-8419-402A-AE04-6D6FE4783949 Q41985946-E7EEE6D3-551D-42CC-A40B-74D5DF5BD919 Q42130838-A607D24C-8282-4F7B-AD45-9A1391BD27F2 Q42931044-4ABF22EC-0CB5-457E-BDCE-7B69DBD05303

P2860

Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview.

http://www.wikidata.org/entity/Q37824829

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 December 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview.

@en

Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview.

@nl

type

label

Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview.

@en

Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview.

@nl

prefLabel

Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview.

@en

Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview.

@nl

P1433

Q37824829-478534E6-2AAC-4337-90A9-FD7BE506FDD6

P1476

Q37824829-25C4A610-8824-44D1-B41A-7D914725C2F6

P2093

Q37824829-098CC789-5F59-43B5-BC2F-CB5989493EE8

Q37824829-3B612114-9275-456F-902B-A519EB0D3241

Q37824829-8ECEB7FB-38DE-43F3-BB4D-3F01FF3F6A1A

Q37824829-D50CECEF-4AB9-4715-ADE7-7F1493C036F8

P2860

Q37824829-0F4E72A3-AC3B-42E1-B2FC-C4CF72EE603F

Q37824829-13DEA960-FBA5-48E8-AED3-F19F72E3C36E

Q37824829-1CEDD8E3-032F-411D-80FD-4902A8BE8074

Q37824829-20DD8D17-5730-430D-A9BF-A97BCE89FE79

Q37824829-2278C802-44E1-4776-A22D-0155114E948B

Q37824829-28AE4F6F-3E10-43E6-9F47-B90DDC48DFC3

Q37824829-31FB17DF-589C-41E0-9364-0AE82F82AEA2

Q37824829-3273A033-08A1-47B4-AE4B-A51D3C465748

Q37824829-333AAEA6-91AC-4622-8454-7063A3775713

Q37824829-367B73FD-DF84-4B5D-B29E-E8ADC22FEFD9

P2888

Q37824829-D1C92861-3E56-4C65-9C96-DC86A2B9D860

P304

Q37824829-87EEEA69-8E65-446F-AA71-7DD3DF74A813

P31

Q37824829-3b6e8689-9b39-466e-ac40-a045f77d987f

Q37824829-E2C7E047-1E1E-4751-A7AE-52EEFF1D305C

P356

Q37824829-6D9BA193-CC4A-4D3D-8A60-3C43FE1775BA

P433

Q37824829-CD65926D-41E6-487F-9EAF-C66A6CDD78B2

P478

Q37824829-53DC6BFC-9BCF-4871-9B39-07BF1BE04018

P577

Q37824829-26B3E8D6-E5E7-4D27-A49A-F09CCE62341C

P698

Q37824829-605AA7DF-4FD1-4389-8404-16E2951A825B

P921

Q37824829-02A25E88-D84B-45C8-9943-56360C2EDBD8

Q37824829-a7c68305-24bd-48a9-af31-a06a1f5e257f

P356

S00432-010-0965-X

P1433

Journal of Cancer Research and Clinical Oncology

P1476

Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview.

@en

P2093

J K Habermann

http://www.w3.org/2001/XMLSchema#string

S Bünger

http://www.w3.org/2001/XMLSchema#string

T Laubert

http://www.w3.org/2001/XMLSchema#string

U J Roblick

http://www.w3.org/2001/XMLSchema#string

P2860

CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA

Minimum information about a microarray experiment (MIAME)-toward standards for microarray data

Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer

Tumor M2-Pyruvate Kinase, a New Metabolic Marker for Pancreatic Cancer

The minimum information about a proteomics experiment (MIAPE)

Measurement error correction using validation data: a review of methods and their applicability in case-control studies.

Plasma storage at -80 degrees C does not protect matrix metalloproteinase-9 from degradation.

Protein profiling of microdissected pancreas carcinoma and identification of HSP27 as a potential serum marker.

Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.

Time-dependent evolution of tissue markers by MALDI-MS imaging.

P2888

s00432-010-0965-x

P304

375-389

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00432-010-0965-X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

137

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21193998

http://www.w3.org/2001/XMLSchema#string

P921